Hepatitis C virus genotype 3a infection and hepatocellular carcinoma: Pakistan experience
- PMID: 19860002
- PMCID: PMC2768888
- DOI: 10.3748/wjg.15.5080
Hepatitis C virus genotype 3a infection and hepatocellular carcinoma: Pakistan experience
Abstract
Aim: To assess the association between chronic hepatitis C virus (HCV) infection and hepatocellular carcinoma (HCC) in Pakistan, and the genotype distribution among these HCC patients.
Methods: One hundred and sixty-one subjects with HCC were included in this study. Liver biopsy was performed on 145 of the patients; sixteen were excluded because they failed to fulfill the inclusion criteria. Qualitative polymerase chain reaction (PCR) was performed for hepatitis B virus and HCV. Samples positive for HCV RNA were genotyped using genotype-specific PCR and confirmed by HCV 5' noncoding region sequencing analysis.
Results: Chronic HCV infection was identified a major risk factor (63.44% of tested HCC patients) for the development of HCC. The time from HCV infection to appearance of cancer was 10-50 years. In the HCC patient population, broader distributions of genotypes were present with genotype 3a as the predominant genotype. Using the type-specific genotyping method, we found HCV genotype 3a in 40.96%, 3b in 15.66%, 1a in 9.63%, and 1b in 2.40% of HCC tissue samples. About 28% of cases were found with mixed genotypes. Two cases were unable to be genotyped because of low viral load. Sixty-six percent of treated patients with cirrhosis had an end of treatment response, but unfortunately they relapsed quickly when the treatment was discontinued, and HCC developed during a median 3.8 years.
Conclusion: There was a strong association between chronic HCV infection and HCC in Pakistan, and between HCV genotype 3a and HCC.
References
- 
    - Moradpour D, Wands JR. The molecular pathogenesis of hepatocellular carcinoma. J Viral Hepat. 1994;1:17–31. - PubMed
 
- 
    - El-Serag HB. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology. 2004;127:S27–S34. - PubMed
 
- 
    - Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362:1907–1917. - PubMed
 
- 
    - Kayali Z, Tan S, Shinkunas L, Voigt M, LaBrecque DR, Stapleton JT, Brown KE, Schmidt WN. Risk factors for hepatitis C fibrosis: a prospective study of United States veterans compared with nonveterans. J Viral Hepat. 2007;14:11–21. - PubMed
 
Publication types
MeSH terms
LinkOut - more resources
- Full Text Sources
- Medical
 
        